Table 5 Differences between MOLab and aPROMISE software regarding histology, risk classification and angiolymphatic invasion.
ISUP | T value and p (MOLab vs aPROMISE) | ||||
|---|---|---|---|---|---|
SUVmax | SUVmean | SUVpeak | MTV | TLA | |
1 | − 3.49; 0.018 | 3.82; 0.013 | 0.79; 0.472 | − 4.30; 0.008 | − 1.30; 0.251 |
2 | − 3.77; 0.002 | 6.31; < 0.001 | 2.64; 0.018 | − 6.61; < 0.001 | − 1.8; 0.092 |
3 | − 2.71; 0.030 | 3.20; 0.015 | 1.73; 0.128 | − 4.94; 0.002 | − 1.15; 0.288 |
4 | − 4.46; < 0.001 | 4.50; < 0.001 | 2.47; 0.031 | − 3.31: 0.007 | − 1.59; 0.141 |
5 | − 4.87; < 0.001 | 5.55; < 0.001 | 3.11; 0.011 | − 5.95; < 0.001 | − 0.16; 0.878 |
Risk | |||||
Intermediate | − 4.36; 0.005 | 4.13; 0.006 | 2.81; 0.031 | − 4.10; 0.006 | − 2.77; 0.033 |
High | − 7.26; < 0.001 | 9.80; < 0.001 | 4.13; < 0.001 | − 9.64; < 0.001 | − 2.23; 0.031 |
Angiolymphatic invasion | |||||
Yes | − 5.67; < 0.001 | 5.34; < 0.001 | 3.61; 0.002 | − 5.67; < 0.001 | − 1.68; 0.111 |
No | − 6.30; < 0.001 | 8.91; < 0.001 | 3.25; 0.003 | − 9.55; < 0.001 | − 2.10; 0.046 |
